S&P 500   5,078.15 (+0.32%)
DOW   37,977.79 (+0.64%)
QQQ   431.17 (+0.03%)
AAPL   169.34 (-1.94%)
MSFT   415.85 (+0.53%)
META   500.32 (+0.02%)
GOOGL   154.60 (-0.17%)
AMZN   183.45 (-0.09%)
TSLA   155.93 (-3.44%)
NVDA   872.75 (+1.48%)
AMD   163.06 (+1.71%)
NIO   3.83 (-1.54%)
BABA   70.07 (-0.78%)
T   16.01 (-1.42%)
F   12.17 (-0.49%)
MU   120.96 (-0.34%)
GE   155.50 (+1.17%)
CGC   6.79 (-2.72%)
DIS   113.88 (+0.82%)
AMC   2.84 (+14.98%)
PFE   25.78 (-0.50%)
PYPL   63.70 (+0.30%)
XOM   118.37 (-1.09%)
S&P 500   5,078.15 (+0.32%)
DOW   37,977.79 (+0.64%)
QQQ   431.17 (+0.03%)
AAPL   169.34 (-1.94%)
MSFT   415.85 (+0.53%)
META   500.32 (+0.02%)
GOOGL   154.60 (-0.17%)
AMZN   183.45 (-0.09%)
TSLA   155.93 (-3.44%)
NVDA   872.75 (+1.48%)
AMD   163.06 (+1.71%)
NIO   3.83 (-1.54%)
BABA   70.07 (-0.78%)
T   16.01 (-1.42%)
F   12.17 (-0.49%)
MU   120.96 (-0.34%)
GE   155.50 (+1.17%)
CGC   6.79 (-2.72%)
DIS   113.88 (+0.82%)
AMC   2.84 (+14.98%)
PFE   25.78 (-0.50%)
PYPL   63.70 (+0.30%)
XOM   118.37 (-1.09%)
S&P 500   5,078.15 (+0.32%)
DOW   37,977.79 (+0.64%)
QQQ   431.17 (+0.03%)
AAPL   169.34 (-1.94%)
MSFT   415.85 (+0.53%)
META   500.32 (+0.02%)
GOOGL   154.60 (-0.17%)
AMZN   183.45 (-0.09%)
TSLA   155.93 (-3.44%)
NVDA   872.75 (+1.48%)
AMD   163.06 (+1.71%)
NIO   3.83 (-1.54%)
BABA   70.07 (-0.78%)
T   16.01 (-1.42%)
F   12.17 (-0.49%)
MU   120.96 (-0.34%)
GE   155.50 (+1.17%)
CGC   6.79 (-2.72%)
DIS   113.88 (+0.82%)
AMC   2.84 (+14.98%)
PFE   25.78 (-0.50%)
PYPL   63.70 (+0.30%)
XOM   118.37 (-1.09%)
S&P 500   5,078.15 (+0.32%)
DOW   37,977.79 (+0.64%)
QQQ   431.17 (+0.03%)
AAPL   169.34 (-1.94%)
MSFT   415.85 (+0.53%)
META   500.32 (+0.02%)
GOOGL   154.60 (-0.17%)
AMZN   183.45 (-0.09%)
TSLA   155.93 (-3.44%)
NVDA   872.75 (+1.48%)
AMD   163.06 (+1.71%)
NIO   3.83 (-1.54%)
BABA   70.07 (-0.78%)
T   16.01 (-1.42%)
F   12.17 (-0.49%)
MU   120.96 (-0.34%)
GE   155.50 (+1.17%)
CGC   6.79 (-2.72%)
DIS   113.88 (+0.82%)
AMC   2.84 (+14.98%)
PFE   25.78 (-0.50%)
PYPL   63.70 (+0.30%)
XOM   118.37 (-1.09%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AxoGen, Inc. stock logo
AXGN
AxoGen
$7.03
$8.85
$3.45
$10.83
$307.14M1.04421,120 shs57,188 shs
Natus Medical Inc stock logo
BABY
Natus Medical
$29.96
$23.53
$37.90
$1.12B0.57165,325 shs22 shs
InMode Ltd. stock logo
INMD
InMode
$17.71
+0.1%
$21.62
$17.29
$48.25
$1.49B2.161.60 million shs679,580 shs
Natus Medical Incorporated stock logo
NTUS
Natus Medical
$32.96
$32.96
$20.90
$33.93
$1.14B0.22325,002 shs1,514 shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AxoGen, Inc. stock logo
AXGN
AxoGen
-2.50%-11.24%-8.46%-11.57%-29.77%
Natus Medical Inc stock logo
BABY
Natus Medical
0.00%0.00%0.00%0.00%0.00%
InMode Ltd. stock logo
INMD
InMode
-1.28%-10.61%-15.40%-17.99%-51.77%
Natus Medical Incorporated stock logo
NTUS
Natus Medical
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AxoGen, Inc. stock logo
AXGN
AxoGen
2.5632 of 5 stars
3.53.00.00.02.52.50.6
Natus Medical Inc stock logo
BABY
Natus Medical
1.8598 of 5 stars
0.00.00.03.90.61.73.1
InMode Ltd. stock logo
INMD
InMode
3.098 of 5 stars
3.23.00.00.02.31.72.5
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AxoGen, Inc. stock logo
AXGN
AxoGen
3.00
Buy$10.6751.73% Upside
Natus Medical Inc stock logo
BABY
Natus Medical
N/AN/AN/AN/A
InMode Ltd. stock logo
INMD
InMode
2.33
Hold$32.8085.21% Upside
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/AN/AN/AN/A

Current Analyst Ratings

Latest BABY, NTUS, INMD, and AXGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/12/2024
InMode Ltd. stock logo
INMD
InMode
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$34.00 ➝ $33.00
4/9/2024
InMode Ltd. stock logo
INMD
InMode
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
2/15/2024
InMode Ltd. stock logo
INMD
InMode
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$32.00 ➝ $34.00
2/14/2024
InMode Ltd. stock logo
INMD
InMode
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$24.00 ➝ $26.00
1/19/2024
AxoGen, Inc. stock logo
AXGN
AxoGen
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$12.00
1/18/2024
InMode Ltd. stock logo
INMD
InMode
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$33.00 ➝ $32.00
(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AxoGen, Inc. stock logo
AXGN
AxoGen
$159.01M1.93N/AN/A$2.22 per share3.17
Natus Medical Inc stock logo
BABY
Natus Medical
$530.89M0.00N/A9.39$11.80 per share0.00
InMode Ltd. stock logo
INMD
InMode
$492.05M3.02$2.19 per share8.10$6.68 per share2.65
Natus Medical Incorporated stock logo
NTUS
Natus Medical
$473.44M2.41$2.02 per share16.34$12.44 per share2.65

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AxoGen, Inc. stock logo
AXGN
AxoGen
-$21.72M-$0.52N/AN/AN/A-13.66%-22.38%-11.24%5/14/2024 (Estimated)
Natus Medical Inc stock logo
BABY
Natus Medical
-$22.93M$1.4223.210.00N/A-7.38%10.79%6.57%N/A
InMode Ltd. stock logo
INMD
InMode
$197.92M$2.307.708.05N/A40.22%29.80%27.02%5/2/2024 (Confirmed)
Natus Medical Incorporated stock logo
NTUS
Natus Medical
$13.18M$0.3789.0820.99N/A2.65%10.15%7.65%N/A

Latest BABY, NTUS, INMD, and AXGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
InMode Ltd. stock logo
INMD
InMode
$0.40N/A-$0.40N/AN/AN/A  
3/5/2024Q4 2023
AxoGen, Inc. stock logo
AXGN
AxoGen
-$0.20-$0.09+$0.11-$0.09$42.70 million$42.92 million
2/13/202412/31/2023
InMode Ltd. stock logo
INMD
InMode
$0.66$0.71+$0.05$0.64$124.77 million$126.80 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AxoGen, Inc. stock logo
AXGN
AxoGen
N/AN/AN/AN/AN/A
Natus Medical Inc stock logo
BABY
Natus Medical
N/AN/AN/AN/AN/A
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AxoGen, Inc. stock logo
AXGN
AxoGen
0.71
2.89
2.14
Natus Medical Inc stock logo
BABY
Natus Medical
0.18
1.70
1.18
InMode Ltd. stock logo
INMD
InMode
N/A
12.51
11.87
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/A
2.54
1.90

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AxoGen, Inc. stock logo
AXGN
AxoGen
80.29%
Natus Medical Inc stock logo
BABY
Natus Medical
91.56%
InMode Ltd. stock logo
INMD
InMode
68.04%
Natus Medical Incorporated stock logo
NTUS
Natus Medical
92.35%

Insider Ownership

CompanyInsider Ownership
AxoGen, Inc. stock logo
AXGN
AxoGen
7.21%
Natus Medical Inc stock logo
BABY
Natus Medical
1.65%
InMode Ltd. stock logo
INMD
InMode
6.92%
Natus Medical Incorporated stock logo
NTUS
Natus Medical
1.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AxoGen, Inc. stock logo
AXGN
AxoGen
42643.69 million40.54 millionOptionable
Natus Medical Inc stock logo
BABY
Natus Medical
1,72934.01 millionN/AOptionable
InMode Ltd. stock logo
INMD
InMode
58183.98 million78.17 millionOptionable
Natus Medical Incorporated stock logo
NTUS
Natus Medical
1,40034.58 million34.17 millionOptionable

BABY, NTUS, INMD, and AXGN Headlines

SourceHeadline
Natus Neuro taps Philips, Medtronic veteran as CEONatus Neuro taps Philips, Medtronic veteran as CEO
massdevice.com - March 6 at 7:54 PM
Route 92 Medical Announces Appointment of Jonathan Kennedy as Chief Financial OfficerRoute 92 Medical Announces Appointment of Jonathan Kennedy as Chief Financial Officer
finance.yahoo.com - September 18 at 9:10 AM
What causes an increase in belly fat?What causes an increase in belly fat?
medicalnewstoday.com - August 24 at 5:08 PM
ADHD / ADDADHD / ADD
medicalnewstoday.com - August 16 at 9:20 PM
Natus Medical IncorporatedNatus Medical Incorporated
thestreet.com - July 14 at 9:58 AM
ICU Monitor Market Expected Growth, Demand and Trends for 2030 | Natus Medical, Comen, Micromed, Nihon Kohden Corp.ICU Monitor Market Expected Growth, Demand and Trends for 2030 | Natus Medical, Comen, Micromed, Nihon Kohden Corp.
marketwatch.com - May 12 at 10:30 PM
Jamie Foxx is reportedly stable and recovering: What we know about his medical complicationJamie Foxx is reportedly 'stable' and 'recovering': What we know about his 'medical complication'
yahoo.com - May 9 at 11:07 PM
BCI and EEG Market 2023 by Sales, Share, Growth Opportunity with Top Players are Medtronic, Natus Medical, Nihon Kohden, NeuroPace IncBCI and EEG Market 2023 by Sales, Share, Growth Opportunity with Top Players are Medtronic, Natus Medical, Nihon Kohden, NeuroPace Inc
marketwatch.com - May 5 at 11:46 AM
Brain Mapping Instruments Market Outlook and Forecast to 2030 | GE Healthcare, Philips Healthcare, Siemens Healthcare, Natus MedicalBrain Mapping Instruments Market Outlook and Forecast to 2030 | GE Healthcare, Philips Healthcare, Siemens Healthcare, Natus Medical
marketwatch.com - May 5 at 11:46 AM
Neonatal Hearing Screening Devices Market Trends Analysis And Research Report to 2029 – Natus Medical, Hill-Rom, MAICO DiagnosticsNeonatal Hearing Screening Devices Market Trends Analysis And Research Report to 2029 – Natus Medical, Hill-Rom, MAICO Diagnostics
marketwatch.com - May 4 at 11:51 PM
Polysomnography Software Market Outlook 2023 and Future Forecast to 2030 | SOMNOmedics, custo med, Cadwell Industries, Natus Medical IncorporatedPolysomnography Software Market Outlook 2023 and Future Forecast to 2030 | SOMNOmedics, custo med, Cadwell Industries, Natus Medical Incorporated
marketwatch.com - April 9 at 8:45 PM
Sleep Apnea Device Market Size, Share, Growth, Trends, Analysis to 2029Sleep Apnea Device Market Size, Share, Growth, Trends, Analysis to 2029
marketwatch.com - March 19 at 10:47 PM
Natus Medical completes acquisition deal with MicromedNatus Medical completes acquisition deal with Micromed
pharmabiz.com - January 19 at 10:35 PM
Natus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SASNatus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SAS
finance.yahoo.com - January 18 at 10:03 AM
Natus Medical closes acquisition of MicromedNatus Medical closes acquisition of Micromed
massdevice.com - January 18 at 10:03 AM
Italy: Natus Medical to acquire Micromed in first transaction since ArchiMed purchaseItaly: Natus Medical to acquire Micromed in first transaction since ArchiMed purchase
laingbuissonnews.com - January 3 at 7:26 AM
Epidemiology News and ResearchEpidemiology News and Research
news-medical.net - October 14 at 12:36 PM
Novanta Set to Join S&P MidCap 400; Six Flags Entertainment to Join S&P SmallCap 600Novanta Set to Join S&P MidCap 400; Six Flags Entertainment to Join S&P SmallCap 600
finance.yahoo.com - July 21 at 7:03 PM
ArchiMed completes acquisition of Natus Medical Incorporated for $1.2 billion total equity valueArchiMed completes acquisition of Natus Medical Incorporated for $1.2 billion total equity value
finance.yahoo.com - July 21 at 2:03 PM
Natus Medical Enters Oversold Territory (NTUS)Natus Medical Enters Oversold Territory (NTUS)
nasdaq.com - June 14 at 7:18 PM
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates TREC, CVET, NTUSSHAREHOLDER ALERT: Halper Sadeh LLP Investigates TREC, CVET, NTUS
apnews.com - June 7 at 6:15 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates NTUS, ACC, KCACSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates NTUS, ACC, KCAC
stockhouse.com - May 13 at 3:28 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates NTUS, ACC, SIMO, PLANSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates NTUS, ACC, SIMO, PLAN
apnews.com - May 9 at 2:01 PM
NATUS MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in ProposeNATUS MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Propose
us.acrofan.com - May 6 at 12:30 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

AxoGen logo

AxoGen

NASDAQ:AXGN
AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.
Natus Medical logo

Natus Medical

NASDAQ:BABY
Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; balance and mobility systems to diagnose and assist in treating balance disorders; and thermoregulation products to control the incubators and warmers. Additionally, it offers jaundice management products; brain injury products; NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Pleasanton, California.
InMode logo

InMode

NASDAQ:INMD
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
Natus Medical logo

Natus Medical

NASDAQ:NTUS
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.